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Abstract
Lymphatic research has progressed rapidly in recent years. Though lymphatic dysfunction has been found in a wide array of
disorders from transplant rejection to cancer metastasis, to date, there is still little effective treatment for lymphatic diseases.
The cornea offers an optimal site for lymphatic research due to its accessible location, transparent nature, and lymphatic-
free but inducible features. However, it still remains unknown whether lymphatic valves exist in newly formed lymphatic
vessels in the cornea, and how this relates to an inflammatory response. In this study, we provide the first evidence showing
that lymphatic valves were formed in mouse cornea during suture-induced inflammation with the up-regulation of integrin
alpha 9. The number of corneal valves increased with the progression of inflammatory lymphangiogenesis. Moreover, we
have detected lymphatic valves at various developmental stages, from incomplete to more developed ones. In addition to
defining the average diameter of lymphatic vessels equipped with lymphatic valves, we also report that lymphatic valves
were more often located near the branching points. Taken together, these novel findings not only provide new insights into
corneal lymphatic formation and maturation, but also identify a new model for future investigation on lymphatic valve
formation and possibly therapeutic intervention.
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Introduction
Accompanying the blood circulation, the lymphatic network
penetrates most tissues in the body and plays critical roles in many
functions, including immune surveillance, body fluid homeostasis,
and fat and vitamin absorption. A wide array of diseases and
conditions has been found to be associated with lymphatic
dysfunction, such as cancer metastasis, transplant rejection,
inflammation, and lymphedema [1,2,3,4,5]. However, to date, there
is still little effective treatment available for lymphatic disorders.
The cornea of the eye offers an ideal site for lymphatic research
[2,6,7]. As a transparent tissue, it is naturally devoid of any
vasculatures at adult age. Nonetheless, lymphangiogenesis (LG,
the development of new lymphatic vessels) can be induced in this
tissue after an inflammatory, infectious, traumatic, or chemical
insult. One great advantage of using the cornea for lymphatic
investigation is that it is both easy and straightforward to evaluate
newly formed lymphatic vessels in this tissue since there are no
pre-existing or background vessels to consider. Experimental data
generated from corneal LG studies are therefore assured of a high
degree of accuracy and reliability.
Anatomically, the lymphatic network differs from that of blood
circulation in that it is a unidirectional channel rather than a circuit.
Interstitial fluid, macromolecules, and leukocytes collected from
tissues first enter blind-ended lymphatic capillaries before they
travel through collecting lymphatic vessels and return to the venous
circulation via the thoracic or right lymphatic duct [1]. To prevent
backflow in the unidirectional channels, lymphatic valves are for-
med in collecting lymphatic vessels. These valves are necessary to
overcome opposing pressure gradients and move lymph along the
lymphaticnetworkinastepwisemanner [8]. Currently, itstillremains
a mystery whether newly formed lymphatic vessels in the cornea are
equipped with the valves, and how their formation correlates with
corneal inflammatory LG, which is the focus of this study.
LG is a complex process involving the interaction of lymphatic
endothelial cells with the extracellular matrix through integrin cell
surface receptors, which are a diverse family of heterodimeric cell
surface transmembrane glycoproteins formed by the association of
a and b subunits [9,10,11]. The specific roles of integrins in
corneal LG are still largely unknown. Previous work from us and
other researchers have demonstrated that integrin a1 and a5 are
involved in corneal inflammatory LG and transplant immunity
[12,13,14,15]. Studies outside the eye have also shown that
integrin a9 (Itga-9) knockout mice die shortly after birth because of
severe systemic lymphatic deficiency [16]. A more recent study has
reported that Itga-9 is expressed on mouse lymphatic valves during
development, and its deficiency leads to valve malformation and
retrograde lymph flow [17]. To this stage, there has been no study
linking Itga-9 to lymphatic vessels in the ocular surface.
In this paper, we have shown, for the first time, Itga-9 expression
is up-regulated during corneal inflammation. The number of Itga-
9
+ lymphatic valves increases as corneal LG progresses, and most
valves are located near the lymphatic branching points. Further-
more, our results indicate that there is a maturation process for
corneal lymphatic valves, which vary morphologically from
incomplete to complete ones. These novel findings not only provide
a new concept in understanding corneal lymphatic formation and
maturation, but may also reveal a new target for therapeutic
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study will offer a new model system to investigate inflammatory
lymphatic valve formationand regulation. Future studies employing
this new model may provide novel insights into a number of
lymphatic disorders occurring outside the eye as well.
Materials and Methods
Mice and anesthesia
Normal adult 8–12 week old male BALB/c mice (Taconic
Farms, Germantown, NY) were used in the experiments. All mice
were treated according to ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research and a protocol
approved by the Animal Care and Use Committee, University of
California, Berkeley. Mice were anesthetized using a mixture of
ketamine, xylazine, and acepromazine (50 mg, 10 mg, and 1 mg/
kg body weight, respectively) for each surgical procedure, and all
efforts were made to minimize suffering.
Induction of corneal inflammatory lymphangiogenesis
The suture-induced inflammatory LG model was used to induce
the growth of new lymphatic vessels into the cornea, as described
previously [18]. Briefly, three 11–0 nylon sutures (AROSurgical,
Newport Beach, CA) were placed into the stroma of central
corneas without penetrating into the anterior chamber. Sutures
were left in place and whole-mount corneas were harvested at 3, 7,
and 14 days post-surgery. The experiments were repeated twice
with a total of 6 mice in each group of study.
Reverse transcriptase and semi-quantitative PCR
The experiments were performed as described previously [12].
Briefly, total RNA was extracted and purified from normal and
inflamed corneas 14 days after suture placement with an RNAeasy
mini-kit from Qiagen (Valencia, CA). Reverse transcription was
performed using the SuperScriptH VILO
TM cDNA synthesis kit from
Invitrogen (Carlsbad, CA). PCR was performed with the PCR
mastermix from Promega (Madison,W I ) .P r i m e rs e q u e n c e sw e r e :
mouse Itga-9, forward 59-TGATCAATATAAAAGGCTTACATT-
TAT-39, reverse 59-CTGATGCTGTTCTCTTCCT-39;m o u s e
GAPDH, forward 59-ACCACAGTCCATGCCATCAC-39,r e v e r s e
59-TCCACCACCCT GTTGCTGTA39. For semi-quantitative
analysis, NIH Image J software was used for normalization and
analysis of the band intensity. The experiments were repeated 3 times.
Immunohistochemical assays with epifluorescence or
confocal microscopy
The experiments were performed according to our standard
protocol [19,20]. Briefly, freshly excised whole-mount tissues
were fixed in acetone for immunofluorescent staining. Samples
were sequentially incubated with purified rabbit-anti-mouse
LYVE-1 (Abcam, Cambridge, MA) and goat-anti-mouse Itga-9
antibodies (R&D Systems, Minneapolis, MN), which were
visualized by FITC-conjugated donkey-anti-rabbit and Cy3-
conjugated donkey-anti-goat secondary antibodies, respectively.
Double-stained samples were covered with Vector Shield
mounting medium (Vector Laboratories, Burlingame, CA) and
examined by an AxioImager M1 epifluorescence deconvolution
microscope with AxioVision 4.8 software (Carl Zeiss AG,
Go ¨ttingen, Germany), or a LSM 510 Meta/NLO Axioplan
confocal microscope with LSM AxioImager software (Carl Zeiss




+ were identified as areas of valve
formation. The total number of lymphatic valves per cornea was
quantified for each time point.
Statistical analysis
Data are expressed as the mean 6 SEM. Statistical analysis was
performed by Student t test for PCR analysis or one-way ANOVA
for time course study of valve counts. Prism software (GraphPad,
La Jolla, CA) were used with P,0.05 considered significant.
Results
Itga-9 expression is up-regulated during corneal
inflammation
It is known that Itga-9 labels lymphatic valves, and its up-
regulation mediates lymphatic valve formation in developing non-
ocular tissues [17]. We first set out to examine whether Itga-9
expression was also up-regulated during corneal inflammatory LG.
To approach this, standard suture placement model was employed
and the expression of Itga-9 was compared between normal and
inflamed corneas 14 days after suture placement. At this time point,
inflammatory LG has reached its peak and the cornea is already
invaded by a large amount of newly formed lymphatics [21]. As
shown in Figure 1, Itga-9 expression in the sutured corneas was
significantly higher than in normal controls (***P,0.001).
Figure 1. Itga-9 expression is increased in inflamed cornea.
(A) Representative micrographs from semi-quantitative RT-PCR analysis
showing that Itga-9 expression is significantly increased in 2 week post-
sutured corneas compared with normal control. (B) Summarized data
from 3 repetitive experiments. ***P,0.001.
doi:10.1371/journal.pone.0021918.g001
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inflamed corneas
To further investigate the expressional pattern of Itga-9 in the
inflamed corneas, we next performed immunofluorescent micro-
scopic assays on sutured corneas 14 days post-surgery. As
demonstrated in Figure 2A, Itga-9 was highly expressed on
luminal valve leaflets of LYVE-1
+ lymphatic vessels. The
expression of Itga-9 was also detected on LYVE-1
+ lymphatic
walls at a lower level. The expression of Itga-9 on corneal
lymphatic valves was further validated by an additional assay on
normal conjunctiva (Figure 2B), which is known to be endowed
with collecting lymphatic vessels [22] and can thereby serve as a
positive control tissue for the valve staining method. Itga-9
+ valves
were observed in LYVE-1
+ normal limbal lymphatic vessels as
well, as shown in Figure 2C.
Time course of lymphatic valve formation during corneal
inflammatory lymphangiogenesis
Having determined that lymphatic valves are present on newly
formed lymphatic vessels in the cornea, we next examined the time
course of lymphatic valve formation during corneal inflammatory
LG. Whole-mount corneas at Day 3, 7, and 14 days after suture
placements were subjected to series of immunofluorescent
microscopic assays using specific antibodies against LYVE-1 and
Itga-9. As presented in Figure 3A, the number of lymphatic valves
increased as corneal LG proceeded. While minimal number of
valves were found in lymphatic vessels in Day 3 and Day 7
corneas, a considerable amount of valves were detected in Day 14
samples. This trend reflecting the time course of lymphatic valve
formation in inflamed corneas was summarized and presented in
Figure 3B (**P,0.01).
Lymphatic valves at different developmental stages in
inflamed corneas
Our further examination on morphological structures of corneal
lymphatic valves on Day 14 corneas revealed that these valves
were presented as band-like structures, similarly as observed in
other tissues during development [17]. We also detected various
shapes of lymphatic valves from incomplete to more developed
ones, possibly indicating an early to late stages of development
(Figure 4, B–D). Mature lymphatic valves in the cornea exhibited
similar shapes as those found in normal conjunctiva, as
demonstrated in Figure 4A.
Lymphatic valves tend to be located near lymphatic
branching points
We next examined the location of the valves along newly
formed lymphatic vessels in the inflamed corneas. Interestingly, it
was found that the lymphatic valves were more often located at or
near the branching points, as demonstrated in Figure 5. The
Figure 2. Itga-9 is expressed on lymphatic valves in inflamed cornea and normal conjunctiva and limbi. Representative micrographs
demonstrating Itga-9 expression on luminal valve leaflets (arrows) of LYVE-1
+ lymphatic vessels in inflamed corneas 2 weeks after suture placement
(A), and normal conjunctiva (B) and limbus (C). Itga-9: red; LYVE-1: green. Original magnification: 200 X (A and B) and 400 X (C).
doi:10.1371/journal.pone.0021918.g002
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the total number of lymphatic valves was 68% in Day 14 corneas.
Moreover, we have measured the diameters of corneal lymphatics
with valves, which averaged about 24.8 +/2 1.0 mm (SEM). No
significant difference was found between the diameters of the
lymphatic vessels hosting valves at the branching points or in the
middle of the vessels (data not shown).
Discussion
In this study, we have provided the first evidence showing that
newly formed lymphatic vessels in the cornea develop valves. With
the progression of corneal inflammatory LG, the lymphatic valve
formation increases as well. In addition to defining the time course
of this process, we have provided detailed information on the
average size of the lymphatic vessels hosting valves, and the likely
locations where the valves tend to form. It is logical that lymphatic
valves tend to be located near the branching points where
lymphatic vessels bifurcate and lymph flow needs to be redirected.
Since lymphatic valve formation occurs after endothelial cells
cover the inner surface of lymphatic walls, it serves as a maturation
index for LG. Our data showing that inflamed lymphatics of early
time points (such as Day 3 and 7) are smaller in size and also not
equipped with valves indicate that these lymphatics are still
immature, and may be more responsive to drug therapy. Allied to
this notion is another recent report from our laboratory showing
that corneal LG can be suppressed within a critical time window
after the inflammatory stimulation and when a blockade of
vascular endothelial growth factor receptors (VEGFR) is initiated
during early- and middle- but not late-stage LG [20].
This study may also provide a new therapeutic target to treat
corneal LG and its related diseases. Since lymphatic valves are
Figure 4. Morphologically distinct stages of lymphatic valve formation in inflamed cornea. Representative micrographs demonstrating a
mature lymphatic valve in normal conjunctiva (A) and various stages of lymphatic valves in inflamed corneas 2 weeks after suture placement (B–D).
(B) Spotted expression of Itga-9 at early stage of valve formation. (C) Thin ring of Itga-9 expression characteristic of intermediate stage of valve
formation. (D) Late stage of valve formation identified by strong band of Itga-9 expression, similarly as seen in normal conjunctiva (A). Itga-9: red;
LYVE-1: green. Original magnification: 400 X. Arrows: lymphatic valves.
doi:10.1371/journal.pone.0021918.g004
Figure 3. Time course of lymphatic valve formation during corneal
inflammation. (A) Representative micrographs demonstrating the incre-
ase of lymphatic valves in sutured corneas with the progression of corneal
inflammatory lymphangiogenesis. Itga-9: red; LYVE-1: green. Original magni-
fication: 50 X. Dashed lines: demarcation between the cornea and conjun-
ctiva. (B) Summarized data from repetitive experiments showing lymphatic
valve quantification at day 3, 7, and 14 after suture placement. **P,0.01.
doi:10.1371/journal.pone.0021918.g003
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hypothesize that future strategies targeting on lymphatic valve
formation, maturation, or maintenance may impede the function
of lymphatic vessels and lead to a better outcome of the diseases.
Moreover, we have demonstrated in this study that Itga-9 is up-
regulated during corneal LG and lymphatic valve formation. A
molecular blockade of the Itga-9 pathway may therefore offer a
novel strategy to treat lymphatic-related diseases in the cornea,
which warrants further investigation.
Beyond its contribution to corneal research, this study bears
broader implications. Forexample, it reveals a new in vivo model
with easy access to a transparent tissue to study pathological
lymphatic valve formation, maturation, and manipulation. Results
from corneal lymphatic valve studies will be readily applicable to
other research fields as well. As proven in the past, the cornea has
provided a powerful tool to study a broad spectrum of angiogenic
processes, whether they pertain to tumor growth and metastasis, or
specific growth factors [6,23,24]. As mentioned earlier, a wide
array of diseases are associated with lymphatic dysfunction in the
body, which can be disabling and even life threatening. It is
hopeful that results from this study will shed some light on our
understanding of pathological lymphatic valve formation as well as
the development of new therapies to treat lymphatic disorders in
general.
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